Businesses Defend Use of Biometrics Amid Facial-Recognition Backlash

May 23, 2019

The Wall Street Journal

“Some companies that use biometric technology worry that the growing backlash against the use of facial recognition for law enforcement could negatively affect their businesses. Facial recognition can be used for applications such as aiding medical diagnosis, validating bank accounts, monitoring drivers for alertness, tracking retail customers for marketing insights and monitoring crowds for safety.”

The Wall Street Journal article addresses the growing controversy over facial recognition technologies, focusing on FDNA’s Face2Gene. Unlike commercial applications, Face2Gene employs AI to analyze facial features for diagnosing genetic disorders, highlighting its vital role in healthcare. FDNA defends its use, emphasizing the technology’s potential to improve diagnostic accuracy and enable early intervention for rare conditions.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading